Particulate Matter and Aerosols

Particulate matter is the mixture of solid particles and liquid droplets suspended in air, classified by aerodynamic diameter into coarse (PM10) and fine (PM2.5) fractions, with even smaller ultrafine particles. It is the air pollutant most consistently and strongly linked to ill health, carrying the largest documented share of the global burden of disease from air pollution.

Definition

Particulate matter (PM) is a complex, suspended mixture of solid and liquid particles of varying size, composition and origin; it is conventionally characterised by aerodynamic diameter, with PM10 (<=10 micrometres) and PM2.5 (<=2.5 micrometres) the size fractions used in health assessment and regulation.

Scope

This topic covers the size-based classification of airborne particles, their sources and composition, how they deposit in the respiratory tract, and the cohort and time-series evidence linking particulate exposure to mortality and to cardiovascular and respiratory disease. It addresses particles as a pollutant class, complementing the gaseous-pollutants topic.

Key concepts

• Aerodynamic diameter and size fractions (PM10, PM2.5, ultrafine)
• Primary versus secondary particles
• Particle composition and sources
• Respiratory deposition and clearance
• Systemic inflammation and oxidative stress
• Long-term versus short-term exposure effects
• Concentration-response and guideline limits

Mechanisms

Particle size governs where inhaled particles deposit: coarse particles lodge largely in the upper airways, while fine and ultrafine particles penetrate to the small airways and alveoli. There they provoke local and systemic inflammation and oxidative stress, and the smallest fractions and soluble constituents can reach the circulation, contributing to endothelial dysfunction and cardiovascular effects. Both short-term peaks and sustained long-term exposure are associated with adverse outcomes.

Clinical relevance

Particulate matter is the air pollutant most strongly tied at the population level to cardiovascular and respiratory morbidity and mortality, and its concentration is a core metric in air-quality surveillance and standard-setting. This entry summarises population-level exposure-outcome evidence and is not a basis for individual diagnosis or treatment.

Epidemiology

Long-term cohort studies, beginning with the Harvard Six Cities and American Cancer Society cohorts and extended in later analyses, link fine particulate exposure to increased cardiopulmonary and lung-cancer mortality, while time-series meta-analyses associate short-term PM2.5 rises with daily mortality and hospital admissions; PM2.5 accounts for the largest fraction of the global air-pollution disease burden.

Evidence & guidelines

The cohort evidence of Pope and colleagues and the time-series meta-analysis of Atkinson and colleagues, together with the American Heart Association scientific statement on particulate matter and cardiovascular disease, provide a consistent body of evidence. The WHO global air quality guidelines (2021) set recommended annual and short-term levels for PM2.5 and PM10.

Debates

Does the composition of particles matter beyond their mass?

Health assessment and standards are based largely on particle mass by size fraction, but evidence suggests chemical composition, source and the ultrafine fraction may carry distinct toxicity, raising the question of whether mass alone fully captures the hazard.

Key figures

• C. Arden Pope III
• Robert D. Brook

Seminal works

• pope-2002
• brook-2010
• atkinson-2014

Frequently asked questions

What is the difference between PM10 and PM2.5?

PM10 refers to particles up to 10 micrometres in aerodynamic diameter, while PM2.5 refers to the finer fraction up to 2.5 micrometres; the smaller PM2.5 particles penetrate deeper into the lungs and are more strongly linked to health effects.

Why is particulate matter considered the most important air pollutant for health?

Fine particulate matter is the pollutant most consistently associated in cohort and time-series studies with cardiovascular and respiratory mortality, and it accounts for the largest share of the global disease burden attributed to air pollution.